title: The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting.
authors.affiliation: Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom. stephenbarclay@doctors.net.uk
authors.forename: Stephen
authors.initials: S
authors.lastname: Barclay
authors.forename: Stanislas
authors.initials: S
authors.lastname: Pol
authors.forename: David
authors.initials: D
authors.lastname: Mutimer
authors.forename: Yves
authors.initials: Y
authors.lastname: Benhamou
authors.forename: Peter R
authors.initials: PR
authors.lastname: Mills
authors.forename: Peter C
authors.initials: PC
authors.lastname: Hayes
authors.forename: Sheila
authors.initials: S
authors.lastname: Cameron
authors.forename: William
authors.initials: W
authors.lastname: Carman
authors.forename: William
authors.initials: W
authors.lastname: Cameron
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000276:immunology; D019337:Hematologic Neoplasms / Q000150:complications / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D017410:Practice Guidelines as Topic
chemical_list: D000970:Antineoplastic Agents